Profile
Antonio Gualberto is the founder of Kura Oncology, Inc. which was founded in 2014.
He held the title of Chief Medical Officer & Head-Development at Kura Oncology, Inc. from 2014 to 2020.
Dr. Gualberto's former jobs include Senior Director-Clinical Development at Pfizer Inc. from 1999 to 2010, Group Head-Clinical Research at Millennium Pharmaceuticals, Inc. from 2010 to 2012, Chief Medical Officer at Zeta Acquisition Corp.
III, Head-Global Clinical Development at EMD Serono, Inc. from 2012 to 2014, and Associate Professor at The Warren Alpert Medical School from 2008 to 2012.
Dr. Gualberto's education history includes a graduate and doctorate degree from the University of Seville in 1990 and an undergraduate degree from Trinidad State Junior College.
Former positions of Antonio Gualberto
| Companies | Position | End |
|---|---|---|
| KURA ONCOLOGY, INC. | Founder | 2020-02-06 |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | 2014-08-31 |
| The Warren Alpert Medical School | Corporate Officer/Principal | 2012-05-31 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 2012-03-31 |
| PFIZER, INC. | Corporate Officer/Principal | 2010-07-31 |
Training of Antonio Gualberto
| University of Seville | Doctorate Degree |
| Trinidad State Junior College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| KURA ONCOLOGY, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Zeta Acquisition Corp. III
 Zeta Acquisition Corp. III MiscellaneousMiscellaneous Zeta Acquisition Corp. III operates as a blank check company. It was organized as a vehicle to investigate and, if such investigation warrants, acquire a target company or business seeking the perceived advantages of being a publicly held corporation. The firm will not restrict its potential candidate target companies to any specific business, industry or geographical location and, thus, may acquire any type of business. The company was founded on November 16, 2007 and is headquartered in Des Moines, IA. | Miscellaneous |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |
- Stock Market
- Insiders
- Antonio Gualberto
